2025 AOPMC Session Evaluation Form

2025 AOPMC Session 1101 Evaluation Form
Plenary Session 1101

Precision Medicine in Parkinson's Disease: The Role of Genetics and Biomarkers

March 21, 2025

08:00 -10:00
Learning Objectives:

1. Discuss the global distribution, clinical features, and mechanisms of the common genetic forms of Parkinson's disease.

2. Describe the process of disease-modifying or personalized therapies for Parkinson's disease based on genetic findings.

3. Recognize biomarkers that could facilitate patient stratification and reflect the disease modification effects of therapies for Parkinson's disease.
Session Evaluation
The session met its learning objectives

Strongly agreeAgreeDisagreeStrongly disagree
The content is relevant to my professional and / or scientific interests.

Strongly agreeAgreeDisagreeStrongly disagree
The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.

Strongly agreeAgreeDisagreeStrongly disagree
The overall session organization was satisfactory and appropriate.

Strongly agreeAgreeDisagreeStrongly disagree
I would recommend this session to a colleague.

Strongly agreeAgreeDisagreeStrongly disagree
Faculty Assessment
Shen-Yang Lim, Kuala Lumpur
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Chin-Hsien Lin, Taipei
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
Taku Hatano, Tokyo
This speaker was able to effectively communicate the content of their presentation

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

Strongly AgreeAgreeStrongly DisagreeDisagreeDid not attend
How would you improve this activity?
Please provide any additional comments
The following category best describes your current major professional activity (choose one):

Patient managementBasic Science researchClinical ResearchTeachingResident/PhD StudentUndergraduate StudentOther
My country:
Should be Empty:

2025 AOPMC Session 1101 Evaluation Form

Plenary Session 1101

Precision Medicine in Parkinson's Disease: The Role of Genetics and Biomarkers